233 related articles for article (PubMed ID: 31708104)
1. LukS-PV induces cell cycle arrest and apoptosis through p38/ERK MAPK signaling pathway in NSCLC cells.
Qiang Y; Ma F; Wang Z; Nie Z; Xu L; Ding P; Ma X
Biochem Biophys Res Commun; 2020 Jan; 521(4):846-852. PubMed ID: 31708104
[TBL] [Abstract][Full Text] [Related]
2. LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells.
Bu S; Xie Q; Chang W; Huo X; Chen F; Ma X
Int J Biochem Cell Biol; 2013 Aug; 45(8):1531-7. PubMed ID: 23702031
[TBL] [Abstract][Full Text] [Related]
3. LukS-PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor.
Zhang P; Yu WW; Peng J; Xu LF; Zhao CC; Chang WJ; Ma XL
Cancer Med; 2019 May; 8(5):2474-2483. PubMed ID: 30955242
[TBL] [Abstract][Full Text] [Related]
4. LukS-PV, a component of Panton-Valentine leukocidin, exerts potent activity against acute myeloid leukemia in vitro and in vivo.
Shan W; Bu S; Zhang C; Zhang S; Ding B; Chang W; Dai Y; Shen J; Ma X
Int J Biochem Cell Biol; 2015 Apr; 61():20-8. PubMed ID: 25601295
[TBL] [Abstract][Full Text] [Related]
5. LukS-PV-Regulated MicroRNA-125a-3p Promotes THP-1 Macrophages Differentiation and Apoptosis by Down-Regulating NF1 and Bcl-2.
Sun XX; Zhang SS; Dai CY; Peng J; Pan Q; Xu LF; Ma XL
Cell Physiol Biochem; 2017; 44(3):1093-1105. PubMed ID: 29179212
[TBL] [Abstract][Full Text] [Related]
6. LukS-PV induces differentiation by activating the ERK signaling pathway and c-JUN/c-FOS in human acute myeloid leukemia cells.
Dai C; Zhang C; Sun X; Pan Q; Peng J; Shen J; Ma X
Int J Biochem Cell Biol; 2016 Jul; 76():107-14. PubMed ID: 27102414
[TBL] [Abstract][Full Text] [Related]
7. Induction of G2/M Cell Cycle Arrest via p38/p21
Pai JT; Hsu MW; Leu YL; Chang KT; Weng MS
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500594
[TBL] [Abstract][Full Text] [Related]
8. Exopolysaccharide from Cryptococcus heimaeyensis S20 induces autophagic cell death in non-small cell lung cancer cells via ROS/p38 and ROS/ERK signalling.
Hao Y; Huang Y; Chen J; Li J; Yuan Y; Wang M; Han L; Xin X; Wang H; Lin D; Peng F; Yu F; Zheng C; Shen C
Cell Prolif; 2020 Aug; 53(8):e12869. PubMed ID: 32597573
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells.
Zhao CC; Yu WW; Qi YJ; Xu LF; Wang ZR; Qiang YW; Ma F; Ma XL
Anticancer Drugs; 2020 Mar; 31(3):223-230. PubMed ID: 31789624
[TBL] [Abstract][Full Text] [Related]
10. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
11. AD-1, a novel ginsenoside derivative, shows anti-lung cancer activity via activation of p38 MAPK pathway and generation of reactive oxygen species.
Zhang LH; Jia YL; Lin XX; Zhang HQ; Dong XW; Zhao JM; Shen J; Shen HJ; Li FF; Yan XF; Li W; Zhao YQ; Xie QM
Biochim Biophys Acta; 2013 Aug; 1830(8):4148-59. PubMed ID: 23583729
[TBL] [Abstract][Full Text] [Related]
12. Is LukS-PV a novel experimental therapy for leukemia?
Shan W; Ma X; Deng F
Gene; 2017 Feb; 600():44-47. PubMed ID: 27916717
[TBL] [Abstract][Full Text] [Related]
13. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
14. (E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5).
Kollipara PS; Jeong HS; Han SB; Hong JT
Br J Pharmacol; 2013 Mar; 168(6):1471-84. PubMed ID: 23082969
[TBL] [Abstract][Full Text] [Related]
15. P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549.
Zhang C; Zhu H; Yang X; Lou J; Zhu D; Lu W; He Q; Yang B
J Cancer Res Clin Oncol; 2010 Mar; 136(3):437-45. PubMed ID: 19727814
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib Induces Apoptosis in NSCLC Cells by Promoting Glutaminolysis and Inhibiting the MEK/ERK Signaling Pathway.
Zhang Y; Liu H; Liu X; Lang L
Discov Med; 2024 Apr; 36(183):836-841. PubMed ID: 38665031
[TBL] [Abstract][Full Text] [Related]
17.
Lin MX; Lin SH; Lin CC; Yang CC; Yuan SY
Anticancer Res; 2018 Jun; 38(6):3435-3445. PubMed ID: 29848694
[TBL] [Abstract][Full Text] [Related]
18. Lappaconitine sulfate induces apoptosis and G0/G1 phase cell cycle arrest by PI3K/AKT signaling pathway in human non-small cell lung cancer A549 cells.
Qu D; Ma J; Song N; Hui L; Yang L; Guo Y; Sang C
Acta Histochem; 2020 Jul; 122(5):151557. PubMed ID: 32622431
[TBL] [Abstract][Full Text] [Related]
19. Schizandrin A can inhibit non‑small cell lung cancer cell proliferation by inducing cell cycle arrest, apoptosis and autophagy.
Zhu L; Wang Y; Lv W; Wu X; Sheng H; He C; Hu J
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34643254
[TBL] [Abstract][Full Text] [Related]
20. Xiaoai Jiedu Recipe Inhibits Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells by Blocking the P38 Mitogen-Activated Protein Kinase (MAPK) Pathway.
Wang Y; Xu C; Xu B; Li L; Li W; Wang W; Wu M
Med Sci Monit; 2019 Oct; 25():7538-7546. PubMed ID: 31590176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
